logo

Transmedics Group (TMDX)



Trade TMDX now with
  Date
  Headline
8/4/2022 8:35:42 PM TransMedics Announces Upsize And Pricing Of Public Offering Of 3.25 Mln Shares At $40.00/shr
4/28/2022 7:50:28 AM TransMedics Receives FDA PMA Approval Of OCS DCD Heart Indication
1/5/2022 8:27:14 PM TransMedics Announces Publication Of OCS Liver PROTECT Trial Results In JAMA Surgery
11/4/2021 7:23:04 AM TransMedics Announces Positive Results From U.S. Randomized OCS DCD Heart Trial
9/29/2021 7:06:58 AM TransMedics: FDA Grants Premarket Approval Of OCS Liver System For Preservation And Assessment Of Donor Livers
9/7/2021 7:21:13 AM TransMedics Gets FDA Approval For Its OCS Heart System Enabling Broader Utilization Of Donor Hearts For Transplantation
7/14/2021 7:06:26 AM TransMedics Trading Halted Today; FDA Advisory Committee To Review Premarket Approval Application For OCS Liver System
6/10/2021 10:56:01 AM TransMedics Announces Scheduling Of OCS Liver FDA Advisory Committee Meeting On July 14